Back to results
US 2022/0411871 A1Published application
Methods and Processes for Non-Invasive Assessment of Genetic Variations
AssigneeSequenom, Inc.
InventorsTaylor Jacob Jensen, Jennifer Geis, Sung Kyun Kim, Cosmin Deciu, Mathias Ehrich
Life of this patent
Estimating the term…
Abstract
Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
Claims18
1-82. (canceled)
A method for detecting one, two, three or four copies of a fetal chromosome or portion thereof in a sample, comprising:
- (a) contacting a sample comprising circulating cell-free nucleic acid from a human pregnant female bearing a fetus with a collection of primer pairs under amplification conditions, wherein each primer pair is specific for nucleic acid sequences located within a target polynucleotide in chromosome 13, chromosome 18 or chromosome 21, and there are at least 4 primer pairs for amplifying target nucleotides for each chromosome, wherein the target polynucleotides are in:
- chromosome 13 polynucleotides of SEQ ID NOs:
- 193-198, 200-204, 206, 208-210, 212-215, or complement thereof;
- chromosome 18 polynucleotides of SEQ ID NOs:
- 216-218, 220-230, 232, or complement thereof;
- and
- chromosome 21 polynucleotides of SEQ ID NOs:
- 234, 236, 238-240, 242-246, 248-253, 255, 256, or complement thereof;
- thereby generating amplicons
- (b) determining amounts of target polynucleotides in each of chromosome 13, chromosome 18 and chromosome 21 for from amplicons in (a);
- and
- (c) quantifying from the amounts of target polynucleotides, one, two, three or four copies of one or more of chromosome 13, chromosome 18, chromosome 21, or portion thereof, in the fetus.
9 more elements
Dependencies are inferred from the claim text.